Improving Research to Build a Brighter Future for People with Hematologic Conditions
Individuals living with hematologic conditions need more evidence-based options for managing their health and improving their quality of life. The ASH Research Collaborative® (ASH RC) is working to accelerate change by making it more efficient to conduct research, from increasing access to high-quality clinical data to making it easier for individuals with hematologic conditions to participate in studies.
The ASH RC is currently focused in two disease areas: One classical hematologic condition, sickle cell disease (SCD), and one malignant hematologic disease, multiple myeloma (MM).
- At the heart of both programs are site-based Research Networks consisting of experts in their respective fields.
- The SCD Research Network fosters collaborative partnerships to accelerate progress in clinical research and improve outcomes for individuals living with SCD by expediting the development of therapeutics and generating high-quality evidence to support clinical decision-making. Learn about the SCD Research Network.
- The MM Research Network is committed to building relationships within the myeloma community, leveraging the power of real-world evidence, and prioritizing research to improve the lives of individuals living with multiple myeloma. Learn about the MM Research Network.
Both Networks are powered by real-world data (RWD) which we call The Data Hub. The Data Hub is designed to be the largest shared information resource with real-world data to serve the hematology community. Access to these data can accelerate research and development, support regulatory decision-making, and help clinics identify opportunities for quality improvement. Learn about the Data Hub